Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background QTc interval monitoring, for the prevention of drug-induced arrhythmias is necessary, especially in the context of coronavirus disease 2019 (COVID-19). For the provision of widespread use, surrogates for 12‑lead ECG QTc assessment may be useful. This prospective observational study compared QTc duration assessed by artificial intelligence (AI-QTc) (Cardiologs®, Paris, France) on smartwatch single‑lead electrocardiograms (SW-ECGs) with those measured on 12‑lead ECGs, in patients with early stage COVID-19 treated with a hydroxychloroquine−azithromycin regimen. Methods Consecutive patients with COVID-19 who needed hydroxychloroquine−azithromycin therapy, received a smartwatch (Withings Move ECG®, Withings, France). At baseline, day-6 and day-10, a 12‑lead ECG was recorded, and a SW-ECG was transmitted thereafter. Throughout the drug regimen, a SW-ECG was transmitted every morning at rest. Agreement between manual QTc measurement on a 12‑lead ECG and AI-QTc on the corresponding SW-ECG was assessed by the Bland-Altman method. Results 85 patients (30 men, mean age 38.3 ± 12.2 years) were included in the study. Fair agreement between manual and AI-QTc values was observed, particularly at day-10, where the delay between the 12‑lead ECG and the SW-ECG was the shortest (−2.6 ± 64.7 min): 407 ± 26 ms on the 12‑lead ECG vs 407 ± 22 ms on SW-ECG, bias −1 ms, limits of agreement −46 ms to +45 ms; the difference between the two measures was <50 ms in 98.2% of patients. Conclusion In real-world epidemic conditions, AI-QTc duration measured by SW-ECG is in fair agreement with manual measurements on 12‑lead ECGs. Following further validation, AI-assisted SW-ECGs may be suitable for QTc interval monitoring. REGISTRATION:ClinicalTrial.govNCT04371744.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hannun, A. Y., Rajpurkar, P., Haghpanahi, M., Tison, G. H., Bourn, C., Turakhia, M. P., & Ng, A. Y. (2019) · Nature Medicine · doi:10.1038/s41591-018-0268-3 · Cited by 3,148
Mechanisms of action of hydroxychloroquine and chloroquine:implications for rheumatology
Schrezenmeier, E., & Dörner, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0372-x · Cited by 1,468
GARABELLI, P., STAVRAKIS, S., ALBERT, M., KOOMSON, E., PARWANI, P., CHOHAN, J., SMITH, L., ALBERT, D., XIE, R., XIE, Q., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12976 · Cited by 98
Chung, E. H., & Guise, K. D. (2015) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2014.10.005 · Cited by 85 · cited 1×
“[3] Some single‐lead ECG devices coupled with artificial intelligence (AI) received US Food and Drug Administration clearance for atrialfibrillation screening [4], but little is known about the feasibility and diagnostic accuracy of their use for QTc assessment [5].”
Castelletti, S., Dagradi, F., Goulene, K., Danza, A. I., Baldi, E., Stramba-Badiale, M., & Schwartz, P. J. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.097 · Cited by 63 · cited 1×
“Previous studies described the utility of various connected ECG recording devices, such as smartphones [15,18], wearable remote monitoring systems [19], smartwatches [6], and mobile cardiac telemetry [16] for QTc monitoring.”
Cited by
Armoundas, A. A., Narayan, S. M., Arnett, D. K., Spector-Bagdady, K., Bennett, D. A., Celi, L. A., Friedman, P. A., Gollob, M. H., Hall, J. L., Kwitek, A. E., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001201 · Cited by 347
“80,81 Nevertheless, the clinical actionability of such approaches remains undetermined.”
BackgroundTransforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice
Khera, R., Oikonomou, E. K., Nadkarni, G. N., Morley, J. R., Wiens, J., Butte, A. J., & Topol, E. J. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.003 · Cited by 264
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide
Svennberg, E., Tjong, F., Goette, A., Akoum, N., Di Biase, L., Bordachar, P., Boriani, G., Burri, H., Conte, G., Deharo, J. C., et al. (2022) · Europace · doi:10.1093/europace/euac038 · Cited by 261
Self-citationMoving towards vertically integrated artificial intelligence development
Zhang, J., Budhdeo, S., William, W., Cerrato, P., Shuaib, H., Sood, H., Ashrafian, H., Halamka, J., & Teo, J. T. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00690-x · Cited by 54
Artificial intelligence-enhanced patient evaluation: bridging art and science
Oikonomou, E. K., & Khera, R. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae415 · Cited by 34
Metadata
- Authors
- Maille, B., Wilkin, M., Million, M., Rességuier, N., Franceschi, F., Koutbi-Franceschi, L., Hourdain, J., Martinez, E., Zabern, M., Gardella, C., Tissot-Dupont, H., Singh, J. P., Deharo, J.-C., & Fiorina, L.
- Venue
- International Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 331
- Pages
- 333-339
- ISSN
- 0167-5273 (ISSN-L)
- OpenAlex
- W3127514899
- Cited by
- 61
- References
- 5
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study. https://app.cochat.ai/papers/10.1016/j.ijcard.2021.01.002
- The paper
- Maille, B., Wilkin, M., Million, M., Rességuier, N., Franceschi, F., Koutbi-Franceschi, L., Hourdain, J., Martinez, E., Zabern, M., Gardella, C., Tissot-Dupont, H., Singh, J. P., Deharo, J.-C., & Fiorina, L. (2021). Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2021.01.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.